Home › Funds › Board of Trustees of The Leland Stanford Junior University › BOLT
Board of Trustees of The Leland Stanford Junior University position in BOLT
BOLT BIOTHERAPEUTICS INC · Health Care
Board of Trustees of The Leland Stanford Junior University reported holding 35,977 shares of BOLT (BOLT BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$132K, representing 0.02% of its reported portfolio and ranking #17 among its reported holdings. Board of Trustees of The Leland Stanford Junior University has disclosed BOLT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Board of Trustees of The Leland Stanford Junior University's BOLT position evolved
Board of Trustees of The Leland Stanford Junior University first disclosed a stake in BOLT in Q3 2023 at 757,097 shares (US$787K). The position peaked in Q1 2024 at 719,546 shares, worth US$1.0M. Across 13 filings, Board of Trustees of The Leland Stanford Junior University increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 35,977 shares valued at US$132K. Notable position changes include a 95% trim in Q2 2025 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 757.10K | $787.38K | New |
| Q4 2023 | 719.55K | $805.89K | Reduce |
| Q1 2024 | 719.55K | $1.01M | Hold |
| Q2 2024 | 719.55K | $539.66K | Hold |
| Q3 2024 | 719.55K | $466.27K | Hold |
| Q4 2024 | 719.55K | $384.96K | Hold |
| Q1 2025 | 719.55K | $287.82K | Hold |
| Q2 2025 | 35.98K | $207.59K | Reduce |
| Q3 2025 | 35.98K | $191.40K | Hold |
| Q4 2025 | 35.98K | $196.72K | Hold |
| Q1 2026 | 35.98K | $145.35K | Hold |
| Q2 2026 | 35.98K | $138.51K | Hold |
| Q3 2026 | 35.98K | $132.40K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BOLT and 13F data
BOLT (BOLT BIOTHERAPEUTICS INC) is a Health Care company. 17 other funds we track also report a position in BOLT — the largest reported positions include Vivo Capital, LLC (US$266K), Lynx1 Capital Management LP (US$113K), PFIZER INC (US$112K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BOLT
- Vivo Capital, LLC 72.41K sh · $266.48K · Q3 2026
- Lynx1 Capital Management LP 30.80K sh · $113.34K · Q3 2026
- PFIZER INC 31.30K sh · $112.07K · Q3 2026
- Nan Fung Group Holdings Ltd 5.00K sh · $18.40K · Q3 2026
More on Board of Trustees of The Leland Stanford Junior University
FAQ
How long has Board of Trustees of The Leland Stanford Junior University held BOLT?
Board of Trustees of The Leland Stanford Junior University has disclosed BOLT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Board of Trustees of The Leland Stanford Junior University's current position in BOLT?
As of Q3 2026, Board of Trustees of The Leland Stanford Junior University holds 35.98K shares of BOLT (BOLT BIOTHERAPEUTICS INC), valued at $132.40K, representing 0.02% of its reported portfolio and ranking #17.
Has Board of Trustees of The Leland Stanford Junior University been buying or selling BOLT?
In the latest 13F filing (Q3 2026), Board of Trustees of The Leland Stanford Junior University held unchanged its position in BOLT. The position peaked in Q1 2024 at 719.55K shares.
Which other funds hold BOLT?
Other major institutional holders of BOLT include Vivo Capital, LLC, Lynx1 Capital Management LP, PFIZER INC, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.